
For research use only. We do not supply to patients.
For pharmaceutical-grade products or other inquiries, please contact our experts.
Sodium oxybate acts as a CNS depressant, binding to GHB and GABAB receptors, and improves sleep architecture by increasing slow-wave sleep and delta power while reducing REM sleep and nocturnal awakenings. Pharmacokinetically, it is rapidly absorbed, with a short half-life, requiring twice-nightly dosing; food delays absorption. In clinical trials, sodium oxybate 4.5–9 g/night significantly reduced cataplexy frequency by up to 85% in a dose-dependent manner and improved excessive daytime sleepiness, as measured by Epworth Sleepiness Scale scores and maintenance of wakefulness tests. Sodium oxybate is effective and well-tolerated, offering a valuable alternative or adjunct to traditional treatments for narcolepsy with cataplexy.
Fig. 1 Effect of Sodium Oxybate on sleep architecture in patients with narcolepsy with cataplexy. (Robinson D M, Keating G M. 2007)
References
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed
All our products are chemicals for research purposes only. We do not supply for human or veterinary applications.
Privacy Policy | Cookie Policy Copyright © Protheragen. All Rights Reserved.
